• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Functional analysis of transcription factor BACH1 on thrombopiesis and megakaryocyte diffrentiation

Research Project

Project/Area Number 15591079
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Pediatrics
Research InstitutionHirosaki University

Principal Investigator

TOKI Tsutomu  Hirosaki University, School of Medicine, Lecturer, 医学部, 講師 (50195731)

Co-Investigator(Kenkyū-buntansha) ITO Etsuro  Hirosaki University, School of Medicine, Professor, 医学部, 教授 (20168339)
Project Period (FY) 2003 – 2004
Project Status Completed (Fiscal Year 2004)
Budget Amount *help
¥3,700,000 (Direct Cost: ¥3,700,000)
Fiscal Year 2004: ¥1,400,000 (Direct Cost: ¥1,400,000)
Fiscal Year 2003: ¥2,300,000 (Direct Cost: ¥2,300,000)
KeywordsTranscription factor / Megakaryocyte / BACH1 / NF-E2
Research Abstract

Object
Approximately 10% of newborn babies with Down's syndrome (DS) are born with a leukemoid reaction commonly called transient myeloproliferative disorder (TMD). A portion of DS patients will develop malignant acute megakaryoblastic leukemia (AMKL) during their first 4 years of life. The human BACH1 gene is localized to chromosome 21q22.1 within the potential DS-associated gene region. We have three objects in this research. First, disclosing the mechanism of the thrombocytopenia caused by the over-expression of transcription factor BACH1 in transgenic mice. Second, finding the target genes of BACH1 by excessive expression of the transcription factor. Third, investigating the contribution of BACH1 gene in developing TMD and AMKL in DS patients.
Results
Electron microscopic analysis of megakaryocytes derived from BACH1 transgenic mice revealed remarkable impairment of demarcation membrane and alpha-granule formation, the vacuolation of mitochondria, and the lower degree of heterochromat … More in content in nuclei. To investigate the proliferative ability of the megakaryocytic progenitor cells, we performed CFU-Meg colony formation assay. But, no difference was detected between transgenic and wild mice. These results suggest that the terminal differentiation and maturation process were impaired in the transgenic mouse megakaryocytes.
Using megakaryocytes developed in vitro culture of liver cells from 13 d. p. c. mouse fetuses in the presence of thrombopoietin, we examined some gene expression. The results of the assay showed the down-regulation of the beta1-tubulin and thromboxane A synthase (TXAS) gene. We also recognized the binding of BACH1 protein to the regulatory elements of TXAS gene by chromatin immunoprecipitation method. These results suggest that BACH1 regulates the megakaryocytic differentiation and maturation by antagonizing the p45NF-E2 activity.
At present, to investigate the function of BACH1 in leukemic cells, we succeeded in establishment of BACH1 overexpressing leukemic cell line by the gene transfection. Less

Report

(3 results)
  • 2004 Annual Research Report   Final Research Report Summary
  • 2003 Annual Research Report
  • Research Products

    (2 results)

All 2005

All Journal Article (2 results)

  • [Journal Article] Transgenic expression of BACH1 transcription factor results in megakaryocytic impairment2005

    • Author(s)
      Tsutomu Toki
    • Journal Title

      BLOOD 105

      Pages: 3100-3108

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Transgenic expression of BACH1 transcription factor esults in megakaryocytic impairment.2005

    • Author(s)
      Tsutomu Toki
    • Journal Title

      Blood 105

      Pages: 3100-3108

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary

URL: 

Published: 2003-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi